Literature DB >> 26068888

PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.

Mariken B de Koning1, Esther D A van Duin, Erik Boot, Oswald J N Bloemen, Jaap A Bakker, Kathryn M Abel, Thérèse A M J van Amelsvoort.   

Abstract

RATIONALE: 22q11 deletion syndrome (22q11DS) is associated with an increased risk for psychotic disorders, suggesting a relationship between genotypes and the pathophysiology of psychotic disorders. Two genes in the deleted region, catechol-O-methyl-transferase (COMT) and proline dehydrogenase (oxidase) 1 (PRODH), contain polymorphisms associated with neuropsychiatric phenotypes.
OBJECTIVES: Here, we explored the association between polymorphisms and full-scale intelligence (FSIQ), startle reactivity (SR) and prepulse inhibition (PPI) in adults with 22q11DS.
METHODS: Forty-five adults with 22q11DS were genotyped for PRODH rs450046, rs372055 and COMT Val(158)Met. Plasma proline levels, FSIQ, SR and PPI were measured.
RESULTS: Thirty-five percent of the subjects were hyperprolinemic with a median proline value of 456 μmol/L. C allele carriers of PRODH rs450046 had a lower FSIQ compared to T allele carriers, indicating the C allele to be a risk allele (C allele: mean FSIQ 60.2 (sd 8.7); T allele: mean FSIQ 73.7 (sd 11.5); F 1,43 = 7.59; p = 0.009; partial η (2) = 0.15). A significant interaction effect of proline levels and COMT Val(158)Met genotype was found for SR (F 1,16 = 7.9; p = 0.01; partial η (2) = 0.33), but not for PPI and FSIQ. In subjects with hyperprolinemia, the COMT Val(158)Met genotype effect on SR was stronger than in subjects with normal proline levels.
CONCLUSIONS: Overall, these data provide further evidence for the risk effect of elevated proline levels combined with the COMT Met allele and support the possibilities of using 22q11DS as a model to investigate genotype effects on psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26068888     DOI: 10.1007/s00213-015-3971-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  61 in total

1.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

Authors:  Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

2.  Functional consequences of PRODH missense mutations.

Authors:  Hans-Ulrich Bender; Shlomo Almashanu; Gary Steel; Chien-An Hu; Wei-Wen Lin; Alecia Willis; Ann Pulver; David Valle
Journal:  Am J Hum Genet       Date:  2005-01-20       Impact factor: 11.025

Review 3.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

4.  Hyperprolinemia is a risk factor for schizoaffective disorder.

Authors:  H Jacquet; C Demily; E Houy; B Hecketsweiler; J Bou; G Raux; J Lerond; G Allio; S Haouzir; A Tillaux; C Bellegou; G Fouldrin; P Delamillieure; J F Ménard; S Dollfus; T D'Amato; M Petit; F Thibaut; T Frébourg; D Campion
Journal:  Mol Psychiatry       Date:  2005-05       Impact factor: 15.992

5.  Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia.

Authors:  Hui Liu; Simon C Heath; Christina Sobin; J Louw Roos; Brandi L Galke; Maude L Blundell; Marge Lenane; Brian Robertson; Ellen M Wijsman; Judith L Rapoport; Joseph A Gogos; Maria Karayiorgou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

6.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Stephan Eliez; Tracy Thompson; Christine Hinard; Lauren Penniman; Carl Feinstein; Hower Kwon; Shuting Jin; Booil Jo; Stylianos E Antonarakis; Michael A Morris; Allan L Reiss
Journal:  Nat Neurosci       Date:  2005-10-23       Impact factor: 24.884

7.  A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects.

Authors:  Panos Roussos; Stella G Giakoumaki; Panos Bitsios
Journal:  Biol Psychiatry       Date:  2009-02-20       Impact factor: 13.382

8.  A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome.

Authors:  R J Shprintzen; R B Goldberg; M L Lewin; E J Sidoti; M D Berkman; R V Argamaso; D Young
Journal:  Cleft Palate J       Date:  1978-01

9.  Analysis of ProDH, COMT and ZDHHC8 risk variants does not support individual or interactive effects on schizophrenia susceptibility.

Authors:  Beate Glaser; Valentina Moskvina; George Kirov; Kieran C Murphy; Hywel Williams; Nigel Williams; Michael J Owen; Michael C O'Donovan
Journal:  Schizophr Res       Date:  2006-07-21       Impact factor: 4.939

10.  Pre-pulse inhibition and antisaccade performance indicate impaired attention modulation of cognitive inhibition in 22q11.2 deletion syndrome (22q11DS).

Authors:  Kathryn Louise McCabe; Rebbekah Josephine Atkinson; Gavin Cooper; Jessica Lauren Melville; Jill Harris; Ulrich Schall; Carmel Maree Loughland; Renate Thienel; Linda Elisabet Campbell
Journal:  J Neurodev Disord       Date:  2014-09-19       Impact factor: 4.025

View more
  5 in total

1.  The use of two different MLPA kits in 22q11.2 deletion syndrome.

Authors:  L J M Evers; J J M Engelen; L M H Houben; L M G Curfs; T A M J van Amelsvoort
Journal:  Eur J Med Genet       Date:  2016-02-24       Impact factor: 2.708

2.  A Mouse Mutation That Dysregulates Neighboring Galnt17 and Auts2 Genes Is Associated with Phenotypes Related to the Human AUTS2 Syndrome.

Authors:  P Anne Weisner; Chih-Ying Chen; Younguk Sun; Jennifer Yoo; Wei-Chun Kao; Huimin Zhang; Emily T Baltz; Joseph M Troy; Lisa Stubbs
Journal:  G3 (Bethesda)       Date:  2019-11-05       Impact factor: 3.154

3.  Lower [18F]fallypride binding to dopamine D2/3 receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: a positron emission tomography study.

Authors:  Esther D A van Duin; Jenny Ceccarini; Jan Booij; Zuzana Kasanova; Claudia Vingerhoets; Jytte van Huijstee; Alexander Heinzel; Siamak Mohammadkhani-Shali; Oliver Winz; Felix Mottaghy; Inez Myin-Germeys; Thérèse van Amelsvoort
Journal:  Psychol Med       Date:  2019-04-02       Impact factor: 7.723

4.  Genetic Determinants of Gating Functions: Do We Get Closer to Understanding Schizophrenia Etiopathogenesis?

Authors:  Rastislav Rovný; Dominika Besterciová; Igor Riečanský
Journal:  Front Psychiatry       Date:  2020-11-25       Impact factor: 4.157

5.  Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response.

Authors:  Bruna S da Silva; Douglas T Leffa; Walter O Beys-da-Silva; Iraci L S Torres; Diego L Rovaris; Marcelo M Victor; Luis A Rohde; Nina R Mota; Carla de Oliveira; Markus Berger; John R Yates; Renuka Sabnis; Ramón Díaz Peña; Alexandre Rosa Campos; Eugenio H Grevet; Lucelia Santi; Claiton H D Bau; Verônica Contini
Journal:  Transl Psychiatry       Date:  2019-11-18       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.